硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 ALDH1A1 抗体对
试剂盒

人 ALDH1A1 抗体对

01AB01622

Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is a cytosolic enzyme primarily responsible for oxidizing a broad range of endogenous and exogenous aldehydes, including retinaldehyde to retinoic acid, which is essential for retinoid signaling and cellular differentiation, as well as detoxifying reactive aldehydes generated by lipid peroxidation and alcohol metabolism. ALDH1A1 is highly expressed in the liver and certain neuronal populations, where it also plays a key role in dopamine metabolism by converting toxic intermediates to less harmful products, thereby protecting neurons from oxidative stress. Clinically, ALDH1A1 is recognized as a robust marker for both normal and cancer stem cells, conferring properties such as self-renewal, chemoresistance, and tumor initiation, and its overexpression is linked to poor prognosis and therapy resistance in several cancers, including ovarian and lung cancer. Furthermore, ALDH1A1 deficiency or dysfunction is implicated in neurodegenerative diseases like Parkinson's disease due to impaired detoxification of neurotoxic aldehydes.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
ALDH1A1
基因别名
ALDC; ALDH1; PUMB1
蛋白别名
aldehyde dehydrogenase 1 family member A1; ALDH1A1
UniProt
P00352
物种
Human

产品详情

靶点名称
ALDH1A1
蛋白名称
aldehyde dehydrogenase 1 family member A1
蛋白别名
Aldehyde dehydrogenase 1A1; 3-deoxyglucosone dehydrogenase; ALDH-E1; ALHDII; Aldehyde dehydrogenase family 1 member A1; Aldehyde dehydrogenase; cytosolic; Retinal dehydrogenase 1; RALDH 1; RalDH1
靶点基因名
ALDH1A1
基因别名
ALDC; ALDH1; PUMB1
UniProt
P00352
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is a cytosolic enzyme primarily responsible for oxidizing a broad range of endogenous and exogenous aldehydes, including retinaldehyde to retinoic acid, which is essential for retinoid signaling and cellular differentiation, as well as detoxifying reactive aldehydes generated by lipid peroxidation and alcohol metabolism. ALDH1A1 is highly expressed in the liver and certain neuronal populations, where it also plays a key role in dopamine metabolism by converting toxic intermediates to less harmful products, thereby protecting neurons from oxidative stress. Clinically, ALDH1A1 is recognized as a robust marker for both normal and cancer stem cells, conferring properties such as self-renewal, chemoresistance, and tumor initiation, and its overexpression is linked to poor prognosis and therapy resistance in several cancers, including ovarian and lung cancer. Furthermore, ALDH1A1 deficiency or dysfunction is implicated in neurodegenerative diseases like Parkinson's disease due to impaired detoxification of neurotoxic aldehydes.